Form 4 for COCH Envoy Medical, Inc.
Accepted 2026-06-04 16:28:22 ET · period of report 2026-05-29 · accession 0000914190-26-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 16:28 | 2026-05-29 | COCH | Lucas Brent T. | CEO, Dir | A - Grant | $0.599 | +32.9K | 329.9K | +11% | +$19.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-05-29 | A | A | 32,856 | $0.599 | 329,946 | D | — | — | (F1) These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |